NCT05147428View on ClinicalTrials.gov

A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

14,442

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

October 1, 2023

Conditions
Alzheimer Disease
Interventions
OTHER

Educational Materials

Educational materials on inappropriate prescribing and deprescribing.

Trial Locations (1)

01605

Umass Chan Medical School, Worcester

Sponsors

Collaborators (1)

Elevance Health
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Harvard Pilgrim Health Care

OTHER

collaborator

Humana Co.Ltd.

INDUSTRY

collaborator

Elevance Health

INDUSTRY

collaborator

HealthCore, Inc.

INDUSTRY

lead

University of Massachusetts, Worcester

OTHER

NCT05147428 - A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease | Biotech Hunter | Biotech Hunter